Discover
ADIL
Adial Pharmaceuticals, Inc.
2.80
10 x 2.70
1 x 2.87
bid
ask
-
0.07
2.44%
6 @ 07:00 PM
2.80 +0.00 (0.00%)
| Ytd | -49.09% | |
| 1y | -65.00% |
2.68
day range
2.81
1.31
52 week range
75.00
| Open | 2.81 | Prev Close | 2.87 | Low | 2.68 | High | 2.81 | Mkt Cap | 6.13M |
| Vol | 43.78K | Avg Vol | 479.35K | EPS | N/A | P/E | N/A | Forward P/E | -0.79 |
| Beta | 1.43 | Short Ratio | 0.65 | Inst. Own | 3.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 2.19 | 200-d Avg | 4.69 | 1yr Est | 7.50 |
| Income Statement | |||
| Operating Expenses | 2.00M | ||
| Research and Development Expense | 432.53K | ||
| Selling, General and Administrative Expense | 1.57M | ||
| Operating Income | -2.00M | ||
| Net Income | -2.02M | ||
| Net Income Common Stock | -2.02M | ||
| Net Income Common Stock (USD) | -2.02M | ||
| Consolidated Income | -2.02M | ||
| Earnings per Basic Share | -1.48 | ||
| Earnings per Basic Share (USD) | -1.48 | ||
| Earnings per Diluted Share | -1.48 | ||
| Earning Before Interest & Taxes (EBIT) | -2.02M | ||
| Earning Before Interest & Taxes (USD) | -2.02M | ||
| Weighted Average Shares | 1.37M | ||
| Weighted Average Shares Diluted | 1.37M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.58M | ||
| Cash and Equivalents (USD) | 4.58M | ||
| Investments | 421.73K | ||
| Investments Non-Current | 421.73K | ||
| Current Assets | 4.80M | ||
| Total Assets | 5.23M | ||
| Current Liabilities | 1.51M | ||
| Total Liabilities | 1.51M | ||
| Accumulated Retained Earnings (Deficit) | -91.99M | ||
| Shareholders Equity | 3.72M | ||
| Shareholders Equity (USD) | 3.72M | ||
| Assets Non-Current | 424.37K | ||
| Goodwill and Intangible Assets | 2.64K | ||
| Trade and Non-Trade Payables | 573.57K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 141.00 | ||
| Net Cash Flow from Financing | 315.28K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.30M | ||
| Issuance (Purchase) of Equity Shares | 315.28K | ||
| Net Cash Flow from Operations | -1.61M | ||
| Share Based Compensation | 147.90K | ||